SANTA MONICA, Calif., May 26, 2015 (GLOBE NEWSWIRE) -- Kite Pharma, Inc., KITE, today announced that Arie Belldegrun, M.D., FACS, Chairman, President and Chief Executive Officer, will present a company overview at the Jefferies 2015 Global Healthcare Conference on June 2, 2015 at 11:00am Eastern Time. The conference will be held in New York, NY.
A live audio webcast of the presentation can be accessed through the Calendar of Events section of the Company's website at ir.kitepharma.com. A replay of the webcast will be available on the Company's website for two weeks following the presentation.
About Kite Pharma
Kite Pharma, Inc., is a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products, with a primary focus on engineered autologous T cell therapy (eACT™) designed to restore the immune system's ability to recognize and eradicate tumors. Kite is based in Santa Monica, CA.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.